JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
ALI HEALTH
00241
BEKE-W
02423
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | ---- | ---- | 21.77%12.93B | ---- | ---- | ---- | 76.52%10.62B | ---- | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | ---- | ---- | -132.89%-444.47M | ---- | ---- | ---- | 0.44%-190.85M | ---- | ---- |
Dividend (income)- adjustment | ---- | ---- | ---- | -331.25%-45.46M | ---- | ---- | ---- | 62.81%-10.54M | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | ---- | ---- | 46.01%67.56M | ---- | ---- | ---- | -60.55%46.27M | ---- | ---- |
Impairment and provisions: | ---- | ---- | ---- | 35.77%394.91M | ---- | ---- | ---- | 349.75%290.86M | ---- | ---- |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | -12.49%37.01M | ---- | ---- | ---- | 27.96%42.3M | ---- | ---- |
-Impairment of goodwill | ---- | ---- | ---- | -62.22%49.61M | ---- | ---- | ---- | --131.29M | ---- | ---- |
-Other impairments and provisions | ---- | ---- | ---- | 162.87%308.29M | ---- | ---- | ---- | 270.96%117.28M | ---- | ---- |
Revaluation surplus: | ---- | ---- | ---- | 221.44%233.83M | ---- | ---- | ---- | 73.31%-192.55M | ---- | ---- |
-Derivative financial instruments fair value (increase) | ---- | ---- | ---- | 504.27%440.67M | ---- | ---- | ---- | -110.95%-109.01M | ---- | ---- |
-Other fair value changes | ---- | ---- | ---- | -147.59%-206.84M | ---- | ---- | ---- | 95.13%-83.54M | ---- | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | -926.40%-1.07B | ---- | ---- | ---- | 59.67%-104.45M | ---- | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | -817.44%-1.15B | ---- | ---- | ---- | ---125.45M | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | 275.37%78.81M | ---- | ---- | ---- | 108.11%21M | ---- | ---- |
Depreciation and amortization: | ---- | ---- | ---- | 31.05%2.51B | ---- | ---- | ---- | 29.51%1.92B | ---- | ---- |
-Amortization of intangible assets | ---- | ---- | ---- | 5.60%152.98M | ---- | ---- | ---- | 23.14%144.87M | ---- | ---- |
Financial expense | ---- | ---- | ---- | 21.11%193.58M | ---- | ---- | ---- | 24.55%159.84M | ---- | ---- |
Exchange Loss (gain) | ---- | ---- | ---- | 58.85%-108.45M | ---- | ---- | ---- | -289.26%-263.51M | ---- | ---- |
Special items | ---- | ---- | ---- | 168.28%226.31M | ---- | ---- | ---- | 157.58%84.36M | ---- | ---- |
Operating profit before the change of operating capital | ---- | ---- | ---- | 20.50%14.89B | ---- | ---- | ---- | 87.24%12.35B | ---- | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | ---- | 83.92%1.03B | ---- | ---- | ---- | 121.11%559.72M | ---- | ---- |
Accounts receivable (increase)decrease | ---- | ---- | ---- | -16.98%-2.01B | ---- | ---- | ---- | -4.27%-1.72B | ---- | ---- |
Accounts payable increase (decrease) | ---- | ---- | ---- | -34.75%910.5M | ---- | ---- | ---- | -28.66%1.4B | ---- | ---- |
Special items for working capital changes | ---- | ---- | ---- | 2.64%-808.69M | ---- | ---- | ---- | -195.38%-830.62M | ---- | ---- |
Cash from business operations | ---- | ---- | ---- | 19.11%14.01B | ---- | ---- | ---- | 128.53%11.76B | ---- | ---- |
Other taxs | ---- | ---- | ---- | 10.65%-1.37B | ---- | ---- | ---- | -104.50%-1.53B | ---- | ---- |
Special items of business | -18.23%8.05B | -11.27%4.74B | -27.59%2.14B | ---- | 32.53%9.85B | 41.74%5.34B | 607.40%2.95B | ---- | 142.10%7.43B | 82.59%3.77B |
Net cash from operations | -18.23%8.05B | -11.27%4.74B | -27.59%2.14B | 23.57%12.64B | 32.53%9.85B | 41.74%5.34B | 607.40%2.95B | 133.62%10.23B | 142.10%7.43B | 82.59%3.77B |
Cash flow from investment activities | ||||||||||
Interest received - investment | 16.07%381.65M | 31.51%292.06M | 160.50%190.87M | 394.62%532.57M | 484.53%328.8M | 688.50%222.09M | 898.20%73.27M | -4.93%107.67M | -35.06%56.25M | -48.37%28.17M |
Dividend received - investment | 101.67%74.37M | -3.15%22.55M | 494.32%26.69M | 44.41%89.49M | -34.51%36.88M | -57.49%23.29M | -65.23%4.49M | -20.42%61.97M | 268.23%56.31M | 364.01%54.77M |
Decrease in deposits (increase) | -293,971.85%-1.1B | -559,736.73%-1.1B | -61,021.53%-359.44M | -6,205.82%-3.76B | -100.59%-373K | -99.69%196K | -99.06%590K | 213.39%61.6M | 26,317.15%63.14M | 13,609.57%63.06M |
Sale of fixed assets | -12.02%9.49M | -5.28%9.21M | -99.34%16K | -95.42%13.56M | -96.33%10.79M | -96.53%9.72M | 1,505.92%2.44M | 21,421.15%296.13M | 12,918.94%293.58M | 59,740.38%280.05M |
Purchase of fixed assets | 29.46%-2.49B | 34.26%-1.51B | 36.13%-810.77M | 44.85%-5.4B | 46.70%-3.53B | 47.34%-2.3B | 40.97%-1.27B | -44.98%-9.8B | -41.04%-6.62B | -71.67%-4.36B |
Selling intangible assets | -14.69%244K | 44.58%240K | 280.77%99K | 69.69%2.56M | -76.44%286K | -82.99%166K | -91.53%26K | 248.27%1.51M | 41.49%1.21M | 202.17%976K |
Purchase of intangible assets | 99.04%-1.14M | 99.04%-1.14M | ---- | 32.47%-113.06M | 2.56%-118.95M | -102.26%-118.95M | 99.56%-249K | -258.67%-167.42M | -4,230.44%-122.08M | -1,986.20%-58.81M |
Sale of subsidiaries | --6.3M | ---- | ---- | 489.75%82.6M | ---- | ---- | ---- | ---21.19M | ---21.19M | ---21.19M |
Acquisition of subsidiaries | ---- | ---- | ---- | 86.32%-22.09M | 95.83%-22.09M | 95.83%-22.09M | ---22.09M | 81.17%-161.48M | 41.65%-529.42M | 37.09%-529.42M |
Recovery of cash from investments | 243.74%4.97B | 169.23%2.84B | 739.71%2.07B | 64.56%2.55B | 8.17%1.45B | 18.76%1.06B | -46.70%246.99M | -72.78%1.55B | -65.79%1.34B | -73.43%889.26M |
Cash on investment | -29.85%-4.76B | -733.90%-2.34B | -924.25%-1.87B | 20.35%-1.16B | -606.58%-3.67B | -10.36%-280.01M | 29.53%-182.92M | 50.67%-1.46B | 80.04%-519.01M | 89.97%-253.73M |
Other items in the investment business | -80.12%39.63M | -70.25%29.08M | 775.70%17.51M | 71.80%372.91M | 23.42%199.33M | -28.47%97.73M | -80.49%2M | 37.58%217.05M | 418.51%161.5M | 950.83%136.62M |
Net cash from investment operations | 46.08%-2.87B | -33.50%-1.75B | 35.84%-734.55M | 26.79%-6.82B | 9.06%-5.32B | 65.31%-1.31B | 40.05%-1.14B | -101.18%-9.31B | -40.50%-5.85B | -51.65%-3.77B |
Net cash before financing | 14.45%5.19B | -25.79%2.99B | -22.36%1.4B | 534.08%5.82B | 186.06%4.53B | 184,251.05%4.03B | 221.03%1.81B | 467.90%918.52M | 245.05%1.58B | 99.48%-2.19M |
Cash flow from financing activities | ||||||||||
New borrowing | 34.14%8.27B | 15.90%5.56B | 16.66%2.92B | 105.40%6.84B | 184.95%6.16B | 259.75%4.8B | 280.86%2.5B | 46.09%3.33B | -5.12%2.16B | -12.56%1.33B |
Refund | -30.78%-6.96B | 7.22%-4.2B | 29.01%-1.55B | -295.96%-6.59B | -367.10%-5.32B | -427.02%-4.52B | -911.04%-2.18B | -37.58%-1.66B | 5.83%-1.14B | -77.13%-858.46M |
Interest paid - financing | -98.53%-167.69M | -111.26%-114.72M | 44.49%-20.82M | -54.67%-106.71M | -94.07%-84.47M | -157.97%-54.3M | -416.06%-37.5M | -197.84%-68.99M | -192.09%-43.52M | -87.65%-21.05M |
Dividends paid - financing | -8.79%-2.88B | 4.64%-2.53B | ---- | -73.21%-2.65B | -73.21%-2.65B | -73.21%-2.65B | ---- | -71.27%-1.53B | -71.27%-1.53B | -71.27%-1.53B |
Absorb investment income | ---- | ---- | ---- | 119.51%180M | ---- | ---- | ---- | --82M | ---- | ---- |
Issuance expenses and redemption of securities expenses | -210.46%-3.91B | -2,502.47%-2B | -1,632.09%-1.33B | -31.12%-1.26B | ---1.26B | -20,338.83%-76.85M | ---76.85M | 42.72%-960.25M | ---- | 73.14%-376K |
Other items of the financing business | -175.93%-42.14M | -227.25%-40.96M | 0.20%8.68M | -269.65%-45.39M | 100.82%55.5M | -9.24%32.19M | 60.28%8.67M | -128.31%-12.28M | -64.12%27.64M | -37.30%35.47M |
Net cash from financing operations | -78.95%-5.91B | -32.54%-3.46B | -129.45%-43.23M | -210.03%-3.94B | -379.38%-3.3B | -129.68%-2.61B | -62.10%146.8M | 26.30%-1.27B | 57.00%-688.42M | -1,912.01%-1.14B |
Effect of rate | -104.07%-9.43M | -6.85%168.61M | 325.44%156.48M | -17.74%132.14M | 61.86%231.61M | 208.71%181.01M | -59.48%-69.41M | 302.97%160.63M | 543.16%143.1M | 193.56%58.63M |
Net Cash | -158.50%-720.01M | -133.11%-470.14M | -30.40%1.36B | 635.41%1.88B | 37.44%1.23B | 224.60%1.42B | 276.73%1.95B | 82.16%-352.07M | 133.25%895.53M | -216.90%-1.14B |
Begining period cash | 25.27%10B | 25.27%10B | 25.27%10B | -2.34%7.98B | -2.34%7.98B | -2.34%7.98B | -2.34%7.98B | -20.07%8.18B | -20.07%8.18B | -20.07%8.18B |
Cash at the end | -1.85%9.27B | 1.19%9.7B | 16.71%11.52B | 25.27%10B | 2.52%9.45B | 35.11%9.59B | 40.44%9.87B | -2.34%7.98B | 22.81%9.21B | -27.65%7.09B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.